Bruce A. Freeman
Vorstandsvorsitzender bei Creegh Pharmaceuticals, Inc.
Aktive Positionen von Bruce A. Freeman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Pittsburgh | Corporate Officer/Principal | - | - |
Creegh Pharmaceuticals, Inc.
 Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Präsident | - | - |
Karriereverlauf von Bruce A. Freeman
Ehemalige bekannte Positionen von Bruce A. Freeman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Gründer | 01.01.2008 | - |
Ausbildung von Bruce A. Freeman
| University of California, Riverside | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
Creegh Pharmaceuticals, Inc.
Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Health Technology |
- Börse
- Insiders
- Bruce A. Freeman
- Erfahrung
